Nexgel, Inc. (NASDAQ:NXGL)
| Market Cap | $1.89M-89.8% |
| Revenue (ttm) | $12.07M+3.4% |
| Net Income | -$6.18M-111.8% |
| EPS | -$14.38-75.2% |
| Shares Out | 487.38K |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 13,478 |
| Open | $3.83 |
| Previous Close | $3.79 |
| Day's Range | $3.68 - $3.94 |
| 52-Week Range | $3.00 - $40.40 |
| Beta | 0.80 |
| Analysts | Hold |
| Price Target | n/a |
| Earnings Date | Nov 16, 2026 |
About NXGL
NEXGEL, Inc. is a company that develops and produces advanced hydrogels and gels. These materials are characterized by their significant water content, aqueous polymer composition, and electron beam cross-linking technology. NEXGEL's diverse product range serves crucial applications across several sectors, including wound care management, medical diagnostic tools, transdermal drug delivery systems, and cosmetic formulations. The company was founded in 1997 and operated under the name AquaMed Technologies, Inc. until it rebranded as NEXGEL, Inc. in November 2019. Its headquarters are located in Langhorne, Pennsylvania.
Nexgel, Inc. Stock Analysis — InsiderScore
Nexgel, Inc. scored higher than 48% of companies evaluated by InsiderBuying, and ranked 24th out of 48 stocks in the healthcare sector.
Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.
Insiders at Nexgel, Inc. bought $757.7K of stock across 2 purchases in the last 90 days, the largest of them $732.7K.
The average purchase added about 58% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.
1 of these purchases was made by someone who held no stock at all beforehand — going from nothing to a position is the strongest form of this signal.
This category carries 35% of the Insider Score.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
1 firm rating NXGL in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Nov 16, 2026Earnings report
$NXGL stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in NXGL holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by NXGL's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
NXGL Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New NXGL patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to NXGL from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in NXGL
| VXFVanguard Extended Market ETF | $8.45K |
| DFASDimensional - US Small Cap ETF | $56.85 |
| DFMCU.S. Micro Cap Portfolio ETF | $37.9 |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from NXGL’s recent data — informational, not investment advice